4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-005575
PRINCIPAL ACCOUNTING OFFICER sold 475 shares at $19.96 ($9,481)
- PRINCIPAL ACCOUNTING OFFICER acquired 840 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-02-23 | Option exercise | +840 | 20,703 | D | ||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-02-24 | Sale | −475 | $19.96 | $9,481 | 20,228 | D |
| Derivatives | |||||||
| Kihara James PRINCIPAL ACCOUNTING OFFICER | 2025-02-23 | Option exercise · Restricted Stock Units | −840 | 0 | D | ||
| Open-market sales · 475 sh · avg $19.96 · $9,481 | |||||||
Loading xslF345X05/form4-02252025_110245.xml…